Targeting Tumor Necrosis Factor Alpha to Mitigate Lung Injury Induced by Mustard Vesicants and Radiation.


Journal

Disaster medicine and public health preparedness
ISSN: 1938-744X
Titre abrégé: Disaster Med Public Health Prep
Pays: United States
ID NLM: 101297401

Informations de publication

Date de publication:
18 Oct 2023
Historique:
medline: 5 12 2023
pubmed: 18 10 2023
entrez: 17 10 2023
Statut: epublish

Résumé

Pulmonary injury induced by mustard vesicants and radiation is characterized by DNA damage, oxidative stress, and inflammation. This is associated with increases in levels of inflammatory mediators, including tumor necrosis factor (TNF)α in the lung and upregulation of its receptor TNFR1. Dysregulated production of TNFα and TNFα signaling has been implicated in lung injury, oxidative and nitrosative stress, apoptosis, and necrosis, which contribute to tissue damage, chronic inflammation, airway hyperresponsiveness, and tissue remodeling. These findings suggest that targeting production of TNFα or TNFα activity may represent an efficacious approach to mitigating lung toxicity induced by both mustards and radiation. This review summarizes current knowledge on the role of TNFα in pathologies associated with exposure to mustard vesicants and radiation, with a focus on the therapeutic potential of TNFα-targeting agents in reducing acute injury and chronic disease pathogenesis.

Identifiants

pubmed: 37848400
pii: S1935789323001787
doi: 10.1017/dmp.2023.178
doi:

Substances chimiques

Irritants 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e553

Auteurs

Rama Malaviya (R)

Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy; Rutgers University, Piscataway, NJ, USA.

Jeffrey D Laskin (JD)

Department of Environmental and Occupational Health and Justice, School of Public Health, Rutgers University, Piscataway, NJ, USA.

Rita Businaro (R)

Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.

Debra L Laskin (DL)

Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy; Rutgers University, Piscataway, NJ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH